top of page
  • By The Financial District

Dr. Oz Owns Stocks In Firms Making Hydroxychloroquine

Dr. Mehmet Oz owns shares of two companies that supply hydroxychloroquine, the anti-malaria drug that he urged the White House to push as a treatment for COVID-19 despite a lack of evidence showing its efficacy, Kelsey Vlamis reported for Business Insider.

Photo Insert: Iconic talk show host Oprah Winfrey called Dr. Oz "America's Doctor." He is now endorsed by Donald Trump.

CNBC first reported he owned stock in the companies on Wednesday, citing a financial disclosure. The document showed Oz and his wife owned at least a $615,000 stake in Thermo Fisher Scientific, a supplier that lists hydroxychloroquine as one of its products.

The disclosures also showed Oz and his wife owned between $15,001 and $50,000 worth of shares in McKesson Corp., which labels and distributes hydroxychloroquine, according to the Food and Drug Administration (FDA).

Hydroxychloroquine is an FDA-approved anti-malaria medicine that has been studied for its effectiveness in treating COVID-19.

The drug was pushed by former President Donald Trump and prescribed by doctors across the country, however, numerous studies have found the drug is not effective in treating COVID-19. The FDA and the World Health Organization both recommend against using it to treat COVID-19.

All the news: Business man in suit and tie smiling and reading a newspaper near the financial district.

Oz, a Republican running for a US Senate seat in Pennsylvania, sent emails to senior White House advisers in the early days of the pandemic promoting hydroxychloroquine as a treatment for COVID-19. The emails were made public last month in a report from the Select House Committee on the Coronavirus Crisis.

Oz, who has been endorsed by Trump, is running for Senate against Pennsylvania Lt. Gov. John Fetterman, who criticized his opponent for having pushed the drug. Fetterman's campaign says its “actually not surprising'” that Oz urged the Trump administration to push research into an unproven COVID treatment.

WEEKLY FEATURE : MVP Group Keeps Lights On During Pandemic

Optimize asset flow management and real-time inventory visibility with RFID tracking devices and custom cloud solutions.
Sweetmat disinfection mat

bottom of page